MAP3K12
Basic information
Region (hg38): 12:53479669-53500063
Previous symbols: [ "ZPK" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP3K12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 0 | 1 |
Variants in MAP3K12
This is a list of pathogenic ClinVar variants found in the MAP3K12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-53481970-TGG-T | Uncertain significance (Mar 01, 2022) | |||
12-53482039-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
12-53482110-C-A | not specified | Uncertain significance (Jun 10, 2022) | ||
12-53482620-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
12-53482632-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
12-53482641-C-T | not specified | Uncertain significance (May 07, 2024) | ||
12-53482663-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
12-53482779-G-T | not specified | Uncertain significance (May 01, 2024) | ||
12-53482786-C-T | Benign (Jun 27, 2018) | |||
12-53482816-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
12-53482822-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
12-53482836-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
12-53482843-G-A | not specified | Uncertain significance (Mar 22, 2022) | ||
12-53482867-G-T | not specified | Uncertain significance (Apr 12, 2022) | ||
12-53482879-A-G | not specified | Uncertain significance (Aug 06, 2021) | ||
12-53482894-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
12-53483073-T-C | not specified | Uncertain significance (Jun 27, 2022) | ||
12-53483082-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
12-53483088-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
12-53483356-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
12-53483377-G-T | not specified | Uncertain significance (Apr 08, 2022) | ||
12-53483388-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
12-53484322-G-C | not specified | Uncertain significance (May 14, 2024) | ||
12-53484342-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
12-53485096-T-C | Falls;Delayed speech and language development | Uncertain significance (Nov 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAP3K12 | protein_coding | protein_coding | ENST00000547035 | 13 | 19574 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.45e-7 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.99 | 332 | 525 | 0.633 | 0.0000306 | 5687 |
Missense in Polyphen | 60 | 172.71 | 0.3474 | 1939 | ||
Synonymous | -1.43 | 234 | 208 | 1.13 | 0.0000111 | 1947 |
Loss of Function | 5.96 | 0 | 41.3 | 0.00 | 0.00000254 | 441 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000364 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be an activator of the JNK/SAPK pathway. Phosphorylates beta-casein, histone 1 and myelin basic protein in vitro.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Core;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;MAPK Cascade;Insulin Signaling;mapkinase signaling pathway;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;VEGF;Regulation of p38-alpha and p38-beta
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.0529
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.72
Haploinsufficiency Scores
- pHI
- 0.399
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.957
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Map3k12
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;protein phosphorylation;JNK cascade;activation of JNKK activity;activation of JUN kinase activity;histone phosphorylation;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;intracellular signal transduction;positive regulation of transcription, DNA-templated;protein autophosphorylation;positive regulation of ERK1 and ERK2 cascade;negative regulation of motor neuron apoptotic process
- Cellular component
- cytoplasm;cytosol;plasma membrane;membrane;growth cone
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;JUN kinase kinase kinase activity;protein binding;ATP binding;protein kinase binding;protein homodimerization activity